MILESTONE PHARMACEUTICALS INC
NASDAQ: MIST (Milestone Pharmaceuticals Inc.)
Kemas kini terakhir: semalam, 2:35PM1.80
0.02 (1.12%)
| Penutupan Terdahulu | 1.78 |
| Buka | 1.81 |
| Jumlah Dagangan | 790,879 |
| Purata Dagangan (3B) | 1,464,482 |
| Modal Pasaran | 152,989,744 |
| Harga / Jualan (P/S) | 77.32 |
| Harga / Buku (P/B) | 4.96 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 Nov 2025 |
| EPS Cair (TTM) | -0.770 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 416.80% |
| Nisbah Semasa (MRQ) | 4.66 |
| Aliran Tunai Operasi (OCF TTM) | -33.87 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -19.45 M |
| Pulangan Atas Aset (ROA TTM) | -41.29% |
| Pulangan Atas Ekuiti (ROE TTM) | -307.27% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menurun |
| Biotechnology (Global) | Bercampur | Menurun | |
| Stok | Milestone Pharmaceuticals Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | 0.63 |
|
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR). |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 4.71% |
| % Dimiliki oleh Institusi | 22.25% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Rtw Investments, Lp | 30 Jun 2025 | 2,506,102 |
| Propel Bio Management, Llc | 30 Jun 2025 | 1,791,557 |
| Alta Fundamental Advisers Llc | 30 Jun 2025 | 1,398,977 |
| Bml Capital Management, Llc | 30 Jun 2025 | 1,136,091 |
| Simplify Asset Management Inc. | 30 Jun 2025 | 990,000 |
| Lion Point Capital, Lp | 30 Jun 2025 | 548,806 |
| Bleichroeder Lp | 30 Jun 2025 | 500,000 |
| Boxer Capital, Llc | 30 Sep 2024 | 309,007 |
| Xtx Topco Ltd | 30 Jun 2025 | 160,963 |
| Valeo Financial Advisors, Llc | 30 Jun 2025 | 130,699 |
| Cascades Capital Asset Management, Llc | 30 Jun 2025 | 67,135 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |